Alignment Healthcare LLC earnings matched, revenue topped estimates

Alignment Healthcare LLC reported Q3 EPS of -$0.04, matching estimates, with revenue of $1.36B, exceeding expectations. The company forecasted Q4 2026 revenue of $1.32B and FY 2026 revenue of $5.25B, slightly below and above analyst consensus, respectively. Its stock price is down 45.72% over the last 3 months and 52.92% over the last 12 months.

Original reporting
Published Oct 29, 2026, 9:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 9:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ALHC
Bearish
medium confidence
Mentioned
$ALHC
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$ALHCBearishMed
01

Why it matters

Earnings in line but guidance below consensus may trigger short-term sell pressure.

02

Market read

The earnings release provides fresh data that could influence trading decisions for ALHC and related small-cap healthcare stocks.

03

What to watch

Recent cost reduction initiatives and potential contract wins not reflected in guidance.

Relevance 7/10Novelty 7/10Timing: post-market today

Background

Alignment Healthcare LLC is a specialty healthcare services provider listed on NASDAQ.

Company-level read

Ticker impact

$ALHCBearishMedium confidence
Context

Q3 earnings posted EPS -$0.04 in line with estimates and revenue $1.36B beating consensus $1.31B; Q4 guidance below consensus.

Expected impact

likely pressure as market prices in weaker guidance

Evidence & confidence

Guidance below consensus suggests revenue slowdown, investors may sell.

Market effects

Healthcare services sector may see modest pullback as guidance misses expectations.

US small-cap healthcare stocks could face slight downside.

Limited to niche healthcare investors.

Counterpoint

Despite guidance miss, the stock may be undervalued given strong cash flow and potential cost cuts.

Key entities

  • Alignment Healthcare LLC

    NASDAQ-listed healthcare services firm reporting Q3 results.

Related articles

$ALHCMedAI 8/10

Alignment Healthcare (ALHC) Q3 2026 Earnings Call Transcript

Alignment Healthcare (ALHC) reported Q3 2026 earnings, with revenue of $1.4B (up 37% YoY) and adjusted gross profit of $142M. The company lowered annual guidance due to higher costs, targeting adjusted gross profit of at least $575M and adjusted EBITDA of $100M. Membership grew 31% YoY to 301,200. ALHC is addressing cost pressures and investing in clinical programs for 2027 growth.

$ALHCMedAI 8/10

What Alignment Healthcare (ALHC) Said on Its Q3 Earnings Call

Alignment Healthcare (ALHC) reduced its 2026 outlook, expecting at least $5.25B revenue, $575M adjusted gross profit, and $100M adjusted EBITDA. Q4 forecasts include 305K membership, $1.32B revenue, and $104M gross profit. Management targets 20% top-line growth in 2027, with plans to enter new markets and improve care model scalability. Stars ratings and provider alignment remain focus areas.

$ALHCMed

Alignment Healthcare: Q3 Earnings Snapshot

Alignment Healthcare Inc. (ALHC) reported a Q3 loss of $8.1 million, matching analyst expectations. Revenue was $1.36 billion, exceeding forecasts. The company expects Q4 revenue of $1.32 billion and full-year revenue of $5.25 billion. Shares have fallen 59% YTD, trading at $8.06 on Thursday.